RBC Capital Markets downgraded Applied Therapeutics Inc (NASDAQ:APLT) stock to "sector perform" from "outperform” citing ...

RBC Capital raised the firm’s price target on Descartes Systems (DSGX) to $133 from $115 and keeps an Outperform rating on the shares. Ahead of Q3 ...

Applied Therapeutics stock (APLT) was down 75% early Friday on news the FDA had declined to approve its drug govorestat, ...

RBC Capital analyst Brian Abrahams maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) on November 25 and set a price ...

RBC Capital analyst Jonathan Atkin maintained a Hold rating on Megaport Ltd. (MGPPF – Research Report) on November 26 and set a price target of ...

Demand for options protection against an equity market crash is rising, even as a post-election rally takes U.S. stocks to ...

Extendicare Inc. has received a target price upgrade from RBC Capital Markets (Analyst Rank#3), which raised its price target to CAD 11 from CAD 9.50. The revision comes on the back of the company’s ...

Strategists see falling inflation, resilient economic growth, and rising earnings driving further returns for the S&P 500 in ...

As an investment banking associate at RBC Capital Markets, MBA graduate Emmanuel Fadahunsi is helping his clients drive ...

Tariffs have taken the spotlight as a policy issue as S&P 500 companies have discussed earnings with analysts since the U.S.